Navigation Links
Texas Fertility Center Introduces Oncofertility Education Program for Physicians and Patients
Date:4/2/2013

Austin, TX (PRWEB) April 02, 2013

A new delivery method for chemotherapy drugs shows promise in protecting a woman’s ovaries and oocytes (eggs) from the damaging side effects of cancer treatment. Nanoparticle arsenic-based drug treatment, designed by scientists at Northwestern Medicine®, works like a Trojan horse to attack cancer cells without destroying healthy tissues, organs and future fertility.

The lab-tested arsenic trioxide breakthrough will potentially help reduce “fertotoxicity,” but what about young men and women currently scheduled to begin cancer treatment?

Texas Fertility Center offers men and women the option of removing and storing sperm or eggs prior to scheduled chemotherapy and cancer treatment that can cause permanent sterility. Sperm preservation can be started the same day that a male patient contacts TFC requesting storage. Oocyte preservation involves a fast-track fertility treatment cycle of ovulation induction using fertility drugs, and an outpatient egg retrieval procedure. The entire process, from consultation to egg storage, can be performed in as few as 10 days, and need not interfere with cancer treatment schedules.

“We are closely watching this trioxide development, but will continue to focus on providing a safety net for concerned men and women currently starting chemotherapy”, says Dr. Thomas Vaughn, a Reproductive Endocrinologist with Texas Fertility Center. “When a couple calls us for help after a cancer diagnosis, we reassure them that sperm or egg freezing can offer them the chance to preserve their future fertility”.

Raising Awareness for Fertility Preservation
Texas Fertility Center spearheads two-pronged educational campaigns to raise awareness about fertility preservation and the benefits of focusing on oncofertility issues as soon as a cancer diagnosis has been made.

Programs for oncologists, radiologists and cancer specialists: The message for oncologists revolves around scheduling fertility preservation in advance of, or even concurrently with, chemotherapy. Texas Fertility Center regularly holds educational programs for specialists serving on the front lines, providing information to share with their patients.

For men and women diagnosed with cancer: Cryopreservation allows a fertility clinic to effectively freeze a woman’s eggs or ovarian tissue, or, a man’s sperm. Texas Fertility Center collateral materials, social media and website pages share a message of hope, and details on making a plan for preserving fertility.

“Oncologists devise and manage comprehensive treatment plans for newly diagnosed cancer patients,” says Dr. Vaughn. “Our goal is to ensure that fertility preservation is provided at the onset as an option for young men and women who want to start or add to their families after cancer.”

Advances in Egg Freezing
Until recently, egg freezing wasn’t a viable option for young women faced with a cancer diagnosis. Eggs, the body’s largest cell, are comprised mainly of water, and historically did not freeze or thaw well. Vitrification, or rapid freezing, eliminates the problem of ice crystals forming during the process.

Today, the first babies born from frozen eggs are celebrating their second birthdays. In fact, Texas Fertility Center reported one of the first live births from a frozen egg in Texas in July 2011.

“Fertility preservation, as well as promising new breakthroughs in cancer treatment, allows young men and women to focus on getting well, without surrendering their dreams of eventually becoming parents ,” adds Dr. Vaughn.

About Texas Fertility Center
Texas Fertility Center (TFC), one of the nation’s leading full-service infertility practices, provides advanced Infertility and Reproductive Endocrinology services to patients throughout Texas, the Southwestern United States, and the Americas. Since 1980, TFC has been recognized nationally for outstanding pregnancy rates, cutting-edge laboratory procedures, and innovative research programs. For more information, please visit http://www.txfertility.com.

Read the full story at http://www.prweb.com/releases/2013/oncofertility/prweb10591337.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Manipulating way bacteria talk could have practical applications, Texas A&M profs say
2. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
3. CuraLase Expands with New Franchise in Texas
4. CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
5. Mining cleanup benefits from Texas A&M expertise
6. United States Rocket Academy Welcomes XCOR Aerospace to Texas
7. Worlds smallest semiconductor laser created by University of Texas scientists
8. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
9. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
10. Why Texas is #1 in Business: Local BioTech Company Expands
11. Texas Teacher May Be Among First Lone Star Astronauts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... in a published evaluation of multiple immunoassay-based threat detection technologies by researchers ... Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have the ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... studies (such as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or ... Salivary Insulin Assay from Salimetrics’ SalivaLab , the relationship between insulin and ...
(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 ... company, and Beyond Type 1, a not-for-profit advocacy and ... today announced a grant from Beyond Type 1 to ... type 1 and other insulin-requiring diabetes.  ... innovative stem cell-derived cell replacement therapies with a focus ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):